MedTrace Logo

Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients

NCT06659237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2024-10-26

No results posted yet for this study

Summary

Significant gaps exist in understanding the gastrointestinal microbiota in patients with pancreatic cancer (PCA) versus benign or low-grade malignant pancreatic tumors (NPCA). This study aimed to analyze these microbiota characteristics and explore their potential use in distinguishing malignant pancreatic lesions.

Conditions

  • Microbiome
  • Pancreatic Neoplasms
  • 16s RRNA

Interventions

DIAGNOSTIC_TEST

16s rRNA or shotgun metagenomics

16s rRNA or shotgun metagenomics on oral and fecal samples

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Menghua Dai, MD · Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2024-05-30
Completion
2024-05-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06659237 on ClinicalTrials.gov